Improvement in systolic function in left ventricular non-compaction cardiomyopathy: A case report  by Lin, Tiffany et al.
Journal of Cardiology Cases 10 (2014) 231–234Case Report
Improvement in systolic function in left ventricular non-compaction
cardiomyopathy: A case report
Tiffany Lin (BS)a, Michael Wesley Milks (MD)a, Bharathi Upadhya (MD)a,
William Gregory Hundley (MD)a,b, Richard Brandon Stacey (MD, MS)a,*
aDepartment of Internal Medicine Section on Cardiology at the Wake Forest University School of Medicine, Winston-Salem, NC, USA
bDepartment of Internal Medicine Section on Radiology at the Wake Forest University School of Medicine, Winston-Salem, NC, USA
A R T I C L E I N F O
Article history:
Received 2 May 2014
Received in revised form 9 July 2014
Accepted 8 August 2014
Keywords:
Heart failure
Cardiomyopathy
Non-compaction
Cardiac magnetic resonance imaging
Echocardiography
A B S T R A C T
This is a case of a 48-year-old man who presented with a pulmonary embolism and was found to have
left ventricular non-compaction cardiomyopathy. Initial echocardiograms demonstrated prominent
apical trabeculations with reduced biventricular function. These ﬁndings were further conﬁrmed and
characterized by cardiac magnetic resonance imaging. He met all major criteria used to identify left
ventricular non-compaction cardiomyopathy. He underwent medical management for heart failure and
during follow-up was noted to have signiﬁcant improvement in left ventricular systolic function and
symptoms. While most management attention is focused on rhythm disturbances or embolic risk,
particular attention should also be exercised to ensure that heart failure medical therapy is optimized.
While many with left ventricular non-compaction cardiomyopathy have irreversible dysfunction, this
case highlights that there may be some who will respond well to aggressive medical therapy. The
diagnosis and medical management of left ventricular non-compaction cardiomyopathy are reviewed in
light of our patient and his clinical course.
<Learning objective: Historically, left ventricular non-compaction cardiomyopathy (LVNC) has been
associated with signiﬁcant morbidity and mortality. Discussion often focuses on sudden cardiac death
and prevention of embolisms. Many of the initial reports and case series were written in an era when
standard medical therapy for congestive heart failure was not yet deﬁned. While many do not respond as
this case did, this case emphasizes that optimal medical therapy can make a substantial difference, even
for LVNC.>
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Isolated left ventricular non-compaction cardiomyopathy
(LVNC) is an uncommon myocardial disorder characterized by
prominent trabeculae and deep intertrabecular recesses forming
thickened myocardium consisting of a thin compacted epicardial
layer and a thickened non-compacted endocardial layer [1]. Initial
case series reported signiﬁcant morbidity and mortality from heart
failure, ventricular arrhythmias, thromboembolism, and sudden
cardiac death among individuals affected with LVNC [2,3]. Given
this association with adverse outcomes, several imaging criteria
have been proposed to identify those with LVNC. As cardiac* Corresponding author at: Cardiology Section, Watlington Hall, Wake Forest
University School of Medicine, Medical Center Boulevard, Winston-Salem, NC
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for cardiac imaging to identify trabeculations, and at times, it is
more difﬁcult to separate the normal from the pathological. More
difﬁcult still is the management of those with LVNC.
Case report
The patient was a 48-year-old Caucasian male with a history of
hyperlipidemia and peripheral vascular disease who presented to
the emergency department with a 4-day history of shortness of
breath, cough, hemoptysis, and bilateral swelling of the legs. He
was found to have a pulmonary embolism via computed
tomography angiography imaging. He also complained of inter-
mittent shortness of breath and symptoms of orthopnea for the
past year. He was still able to carry out his job as a construction
worker, albeit with reduced workload tolerance. His vital signs on
presentation showed a heart rate of 78 beats per minute with a
blood pressure of 148/102 mmHg. His oxygen saturation was 94%. reserved.
Fig. 1.
Initial echocardiogram with apical 3-chamber view presented with (center) and without (left) color ﬂow Doppler to demonstrate blood ﬂow within the trabecular
recesses. Apical 2-chamber view shown to demonstrate trabeculations (right).
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mild tachypnea, but the lungs were clear to auscultation.
Symmetric bilateral lower extremity edema and tenderness to
right lower extremity were also present. His 12-lead electrocar-
diogram showed non-speciﬁc anterior T-wave abnormalities.
The initial transthoracic echocardiogram showed prominent
trabeculations in both the left and right ventricular apex with
severely reduced left ventricular ejection fraction (LVEF) of 15–20%
as well as color ﬂow Doppler in the trabecular recesses (see Fig. 1
and Movie 1). The ratio of non-compacted to compacted
myocardium by echocardiography was 2.4 at end-diastole and
2.1 (normal: <2) at end-systole from the short-axis apical slices.Fig. 2. Cardiac magnetic resonance imaging of 4-chamber view (left) and 3-chambCardiac magnetic resonance imaging (MRI) demonstrated a
moderately dilated left ventricle with a severely reduced LVEF
of 11% (see Fig. 2 and Movie 2). Trabecular mass to total mass ratio
was 50% (normal: <20%), the ratio of non-compacted to compacted
myocardial thickness was 2.6 at end-diastole from the apical short
axis view (normal: <2.3), and the ratio of non-compacted to
compacted myocardial thickness was also 2.3 at end-systole from
the same view (normal: <2). In reviewing the long-axis views, the
average of the end-diastolic non-compacted to compacted ratios
from the 3 long-axis views was 3.3 (normal: <2.3). These
measurements conﬁrmed the diagnosis of LVNC. There was no
late gadolinium enhancement seen during the MRI study, nor waser view (right) to demonstrate trabeculations.
Fig. 3.
Echocardiogram 1 year after presentation with continued ﬂow by color Doppler of the trabeculated recesses (left). Apical 2-chamber view of end-diastole (center)
and end-systole (right) to demonstrate improved left ventricular systolic function.
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to suggest a stress-related response. Of note, the right ventricular
apical trabecular thickness was 45 mm [4].
The patient was referred to the cardiology service and was
treated with furosemide, carvedilol, and lisinopril for the
management of heart failure. One year later, the patient was able
to work with little restriction and was classiﬁed as having New
York Heart Association Class I heart failure. Echocardiogram
demonstrated a normal left ventricular size and an improved LVEF
of 55%. Trabeculations were still present and unchanged in the left
ventricular apex (see Fig. 3 and Movie 3). Interestingly, the initial
echocardiogram showed a biplane left ventricular end-diastolic
volume of 210 ml, and the follow-up echocardiogram 1 year later
showed a left ventricular end-diastolic volume of 145 ml, which
shows that the patient did have reverse remodeling during his
clinical follow-up. The patient was also noted during his
presentation to have dysmorphic features suggestive of an
underlying genetic abnormality. He was offered genetic counseling
and testing but declined.
Discussion
There are several inherent challenges in interpreting the
images of those with potential LVNC. First, there are several ways
to quantify trabeculations and identify those with LVNC. During
the 1980s, multiple case reports and series identiﬁed reduced left
ventricular systolic function with increased trabeculations as a
new etiology of heart failure. Chin et al. [2] presented the ﬁrst set
of criteria which sought to use the x:y ratio, which compares the
thickness of the non-compacted layer with its deepest recess.
Due to technical issues present both then and now, it continues to
be difﬁcult to consistently measure this ratio. As such, Jenni’s
group proposed echocardiographic criteria which sought, among
other things, to describe a thickened left ventricular wall
presenting with a bi-layered structure that consisted of a non-
compacted to compacted wall thickness ratio of >2:1 at end-
systole [3]. In addition, it was paramount to demonstrate Doppler
ﬂow in the trabecular recesses, as well as to exclude the presenceof other congenital anomalies. These criteria were subsequently
validated in a separate population [5]. With the increasing use of
cardiac MRI, Petersen et al. [6] translated the measurements from
the Jenni criteria to MRI by using an end-diastolic non-compacted
to compacted ratio >2.3. Further still, Jacquier et al. [7] proposed
the trabeculated mass-to-total left ventricular mass ratio,
which had a sensitivity of 93% and a speciﬁcity of 94%. While
many have noted that the right ventricle is more trabeculated
than the left ventricle, it makes identifying those with pathologi-
cal trabeculations more difﬁcult. Previously, the thickness of
the trabeculations present in the right ventricular apex was found
to be a more speciﬁc ﬁnding in those with signiﬁcant left
ventricular trabeculations [4].
Second, it is unclear if these different criteria are identifying the
same patients. From the Multi-Ethnic Study of Atherosclerosis, it
was found that the end-diastolic ratio from cardiac MRI was >2.3
in 43% of participants [8]. Using the short-axis measurements,
Dawson et al. [9] demonstrated that 3% of normal volunteers had
an end-diastolic ratio >2. However, none of the participants had an
end-systolic ratio >2. Comparing the end-diastolic and end-
systolic ratio in a trabeculated population, we demonstrated that
the end-systolic ratio was more strongly associated with clinical
events that were historically associated with LVNC [10]. This
ﬁnding suggests that different criteria may capture different levels
of information. Our patient meets end-diastolic criteria both at
initial presentation as well as at follow-up, but he meets end-
systolic criteria only at initial presentation, not at follow-up. These
observations invite several questions: Does the presence of
increased trabeculations at end-diastole indicate risk of future
decline in systolic dysfunction? Do increased trabeculations
further increase the risk and complications in those with left
ventricular systolic dysfunction? With no deep venous thrombosis
to account for the embolism, could the right ventricular
trabeculations have served as the origin? Some of the initial case
reports involved younger patients who presented with pulmonary
embolism in absence of deep venous thrombosis, which suggested
in some cases that right ventricular trabeculations may serve as a
limited nidus for clot formation, much as trabeculations have
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located within the left ventricle [3].
Third, there are no overt guidelines for the medical
management of patients with LVNC. Symptomatic patients with
heart failure should be treated based on clinical presentation
with established medical management, including b-blockers,
angiotensin-converting enzyme inhibitors, and diuretics,
according to consensus guidelines [11]. Our patient demon-
strated a rather robust response to standard heart failure
therapy, which is often not encountered in those with
documented LVNC. Nevertheless, those with LVNC should be
consistently optimized with standard medical therapy, since
some cases may respond well. While medical therapy may
account for some of the improvement in left ventricular systolic
function, it is difﬁcult to know for sure the exact reasons why
our case had such a dramatic improvement. Conversely, the
initial left ventricular functional decline may have represented
an abnormal stress-related response.
Treatment is also concentrated on preventing the develop-
ment or recurrence of complications with prognostic relevance,
such as heart failure, ventricular arrhythmias, or cardioembo-
lism [12]. Routine use of anticoagulation to prevent thrombo-
embolism in patients with LVNC remains controversial. While
there are no robust data to support it, most centers recommend
anticoagulation in those with atrial ﬁbrillation, LVEF <40%,
previous history of embolic events, or those with known
ventricular thrombi [12–14]. Given our patient’s pulmonary
embolism, he was placed on anti-coagulation. Our discussion
concerning a potential implantable cardiac deﬁbrillator was
deferred given the results of his follow-up imaging and
improvement in symptoms as well as absence of signiﬁcant
ventricular ectopy. In general, patients who are asymptomatic
and have normal left ventricular systolic function usually have
good prognosis and would only require follow-up every 2–3
years with clinical assessment and echocardiography
[12]. Asymptomatic patients with echocardiographic evidence
of systolic dysfunction are recommended to have evidence-
based medical heart failure therapy and follow-up every 1–2
years [12]. Since LVNC is associated with potential genetic
underpinnings and familial occurrences, comprehensive clinical
screening is recommended in all ﬁrst-degree relatives of
patients diagnosed with LVNC [13].
Conclusion
While many with LVNC do not improve, even with aggressive
medical therapy, there may be a select subpopulation of patients
with LVNC who are able to respond to intervention.Funding
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